The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

New England Journal of Medicine

Volumn 327, Issue 6, 1992, Pages 369-373

  Donahue, James G ^a   Muñoz, Alvaro ^a   Ness, Paul M ^b   Brown, Donald E ^a   Yawn, David H ^c   Mcallister, Hugh A ^d   Reitz, Bruce A ^b   Nelson, Kenrad E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d St Luke's Episcopal Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; DOSE RESPONSE; ENZYME IMMUNOASSAY; FEMALE; HEART SURGERY; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PRIORITY JOURNAL; RISK; SEROCONVERSION; SEROEPIDEMIOLOGY;

ALANINE TRANSAMINASE; BLOOD DONORS; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS C; HUMAN; PROSPECTIVE STUDIES; RISK; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026747914     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199208063270601     Document Type: Article

References (27)

1. Stevens CE, Aach RD, Hollinger FB, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984; 101: 733–8.
2. Alter HJ, Purcell RH, Holland PV, Ailing DW, Koziol DE. Donor transaminase and recipient hepatitis: impact on blood transfusion services. JAMA 1981; 246: 630–4.
3. Aach RD, Lander JJ, Sherman LA, et al. Transfusion-transmitted viruses: interim analysis of hepatitis among transfused and nontransfused patients. In: Vyas GN, Cohen SN, Schmid R, eds. Viral hepatitis. Philadelphia: Franklin Institute Press, 1978:383–96.
4. Williams AE, Dodd RY. The serology of hepatitis C virus in relation to post-transfusion hepatitis. Ann Clin Lab Sci 1990; 20: 192–9.
5. Koziol DE, Holland PV, Alling DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104: 488–95.
6. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–62.
7. Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4.
8. Cohen ND, Muñoz A, Reitz BA, et al. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med 1989; 320: 1172–6.
9. Nagachinta T, Stephens M, Reitz B, Polk BF. Risk factors for surgical-wound infection following cardiac surgery. J Infect Dis 1987; 156: 967–73.
10. Cox DR, Snell EJ. Analysis of binary data. 2nd ed. London: Chapman & Hall, 1989.
11. Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the Transfusion-Transmitted Viruses Study. N Engl J Med 1981; 304: 989–94.
12. Dienstag JL. Non-A, non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention. Gastroenterology 1983; 85: 743–68.
13. Possible transfusion-associated acquired immune deficiency syndrome (AIDS) — California. MMWR 1982; 31: 652–4.
14. Bove JR. Transfusion-associated hepatitis and AIDS: what is the risk? N Engl J Med 1987; 317: 242–5.
15. Alter HJ, Jett BW, Polito AJ, et al. Analysis of the role of hepatitis C virus in transfusion-associated hepatitis. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1991:396–402.
16. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis — an analysis with first- and second-generation assays. N Engl J Med 1991; 325: 1325–9.
17. Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–7.
18. Lee S-D, Hwang S-J, Lu R-H, Lai K-H, Tsai Y-T, Lo K-J. Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis. J Infect Dis 1991; 163: 1354–7.
19. Tremolada F, Casarin C, Tagger A, et al. Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 1991; 114: 277–81.
20. Hanson MR, Polesky HF. Evaluation of routine anti-HBc screening of volunteer blood donors: a questionable surrogate test for non-A, non-B hepatitis. Transfusion 1987; 27: 107–8.
21. Dienstag JL, Alter HJ. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. Semin Liver Dis 1986; 6: 67–81.
22. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–500.
23. Bradley DW, Maynard JE. Etiology and natural history of post-transfusion and enterically-transmitted non-A, non-B hepatitis. Semin Liver Dis 1986; 6: 56–66.
24. Larsen J, Hetland G, Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 1990; 30: 431–2.
25. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 1991; 338: 1040–1.
26. Esteban JI, González A, Hernández JM, et al. Open prospective efficacy trial of anti-HCV screening of blood donors to prevent posttransfusion hepatitis: interim report of the Barcelona PTH study. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1991:431–3.
27. Shibata M, Morishma T, Kudo T, Maki T, Maki S, Nagai Y. Serum hepatitis C virus sequences in posttransfusion non-A, non-B hepatitis. Blood 1991; 77: 1157–60.